
               
               
               
                  7Â  DRUG INTERACTIONS 

               
               
               
                  
                     
                        
                            Inhibitors of CYP3A4: increased severity of adverse reactions (7.1)
                        
                     
                  
               
               
                  
                     
                     
                     
                        7.1 CYP3A Inhibitors 

                     
                     
                        Exercise caution in patients concurrently taking drugs known to inhibit drug metabolism by hepatic cytochrome P450 isoenzymes in the CYP3A subfamily. Concurrent administration of vinorelbine with an inhibitor of this metabolic pathway may cause an earlier onset and/or an increased severity of adverse reactions.
                     
                     
                  
               
            
         